build leaf glp 1 review GLP-1 Up VOL.U.LIFT™ GLP-1 4D Skin Rebound
Description
Peak GLP-1 increases were significantly higher (~32%) after RYGB at both follow-ups (p<0.05)
Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate.
In addition to todays resource, please see and review the New York Times article, The Risks of Taking Drugs Like Ozempic When Youre Over 65: Medications that cause drastic weight loss raise specific concerns for older adults
ClinicalTrials+1 If these trials succeed, we may see GLP-1 drugs formally approved for brain-health or dementia-prevention in the coming years
